Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ramipril
Drug ID BADD_D01909
Description Ramipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Ramipril may be used in the treatment of hypertension, congestive heart failure, nephropathy, and to reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events.
Indications and Usage For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. [FDA Label] To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy. [T116]
Marketing Status approved
ATC Code C09AA05
DrugBank ID DB00178
KEGG ID D00421
MeSH ID D017257
PubChem ID 5362129
TTD Drug ID D01STB
NDC Product Code 76282-671; 53104-7573; 50090-5730; 50090-5947; 57237-225; 62135-273; 63629-1254; 65841-701; 65862-475; 68180-590; 70518-3038; 71205-029; 65862-476; 57237-222; 60760-476; 61570-111; 62135-274; 68001-429; 0054-0108; 71335-1057; 51655-904; 63187-277; 65841-656; 65841-657; 65841-700; 65841-702; 62135-271; 63187-073; 65841-699; 65862-477; 0054-0106; 68382-145; 68382-147; 68382-376; 71335-0894; 71335-1056; 76282-672; 55111-057; 16729-152; 50090-4691; 51655-296; 61570-110; 63187-816; 68382-146; 82348-101; 16729-153; 45865-441; 51655-347; 51655-406; 61570-112; 63187-644; 65841-655; 65841-658; 68180-589; 68382-144; 70518-1200; 76282-670; 17404-1021; 16729-154; 50090-5673; 60760-571; 63187-854; 63187-915; 0054-0109; 68382-375; 65862-320; 65862-474; 68554-0004; 51655-346; 60760-481; 62135-272; 68001-428; 0054-0107; 68180-591; 71205-080; 58032-0123; 16729-155; 45865-443; 51655-975; 68001-430; 68001-431; 71335-9645; 76282-673; 69037-0051; 61570-120; 68382-374; 68382-377; 15308-0300; 57237-223; 57237-224
UNII L35JN3I7SJ
Synonyms Ramipril | Vesdil | Triatec | Altace | Zabien | Ramace | Tritace | Acovil | Delix | Carasel | HOE-498 | HOE 498 | HOE498
Chemical Information
Molecular Formula C23H32N2O5
CAS Registry Number 87333-19-5
SMILES CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nodal arrhythmia02.03.03.0200.000233%Not Available
Odynophagia07.01.06.0360.000093%Not Available
Oedema14.05.06.010; 08.01.07.0060.000625%Not Available
Oedema mouth23.04.01.008; 10.01.05.006; 07.05.04.0010.000280%Not Available
Oedema mucosal08.01.06.0120.000186%Not Available
Oedema peripheral14.05.06.011; 02.05.04.007; 08.01.07.0070.001445%
Oesophageal pain07.01.05.0120.000093%
Oligohydramnios18.05.01.0010.000746%Not Available
Oliguria20.01.03.0040.000233%Not Available
Onycholysis23.02.05.004--Not Available
Oral discomfort07.05.05.0010.000280%Not Available
Oral pain07.05.05.0340.000140%
Oropharyngeal swelling23.04.01.013; 22.04.05.005; 10.01.05.014; 07.05.04.0020.000186%Not Available
Orthopnoea02.11.05.010; 22.02.01.0200.000093%Not Available
Orthostatic hypotension24.06.03.004; 17.05.01.0200.001072%Not Available
Osteoarthritis15.01.04.0010.000140%Not Available
Pain in jaw15.02.01.0030.000466%Not Available
Pallor24.03.04.001; 23.03.03.031; 08.01.03.0320.000811%Not Available
Palpitations02.11.04.0120.002238%
Pancreatic carcinoma16.13.10.001; 07.21.09.0020.000186%Not Available
Pancreatitis07.18.01.0010.000280%
Pancreatitis acute07.18.01.0020.000886%Not Available
Pancytopenia01.03.03.003--Not Available
Panic attack19.06.04.0010.000513%Not Available
Paraesthesia23.03.03.094; 17.02.06.0050.001632%
Paranoia19.05.01.0050.000140%Not Available
Parosmia22.04.03.007; 17.04.04.0020.000606%Not Available
Pemphigoid23.03.01.004; 10.04.02.0020.000513%Not Available
Pemphigus23.03.01.005; 10.04.02.0030.000280%Not Available
Peripheral coldness23.06.04.008; 24.04.03.006; 08.01.09.0100.000513%Not Available
The 12th Page    First    Pre   12 13 14 15 16    Next   Last    Total 23 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene